Cargando…
Platelet biomarkers identifying mild cognitive impairment in type 2 diabetes patients
Type 2 diabetes mellitus (T2DM) is an independent risk factor of Alzheimer's disease (AD). Therefore, identifying periphery biomarkers correlated with mild cognitive impairment (MCI) is of importance for early diagnosis of AD. Here, we performed platelet proteomics in T2DM patients with MCI (T2...
Autores principales: | Yu, Haitao, Liu, Yanchao, He, Ting, Zhang, Yao, He, Jiahua, Li, Mengzhu, Jiang, Bijun, Gao, Yang, Chen, Chongyang, Ke, Dan, Liu, Jianjun, He, Benrong, Yang, Xifei, Wang, Jian‐Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520722/ https://www.ncbi.nlm.nih.gov/pubmed/34528736 http://dx.doi.org/10.1111/acel.13469 |
Ejemplares similares
-
Platelet biomarkers for a descending cognitive function: A proteomic approach
por: Yu, Haitao, et al.
Publicado: (2021) -
Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes
por: Yu, Haitao, et al.
Publicado: (2022) -
Integrated analyses of brain and platelet omics reveal their common altered and driven molecules in Alzheimer's disease
por: Yu, Haitao, et al.
Publicado: (2022) -
Dauricine Attenuates Spatial Memory Impairment and Alzheimer-Like Pathologies by Enhancing Mitochondrial Function in a Mouse Model of Alzheimer's Disease
por: Chen, Chongyang, et al.
Publicado: (2021) -
Proteomic Profile of Mouse Brain Aging Contributions to Mitochondrial Dysfunction, DNA Oxidative Damage, Loss of Neurotrophic Factor, and Synaptic and Ribosomal Proteins
por: Li, Yingchao, et al.
Publicado: (2020)